Gwaje-gwajen Clinical Biased Yana nufin Ba Mu Koyaushe Sanin Yadda Magani ke Shafar Mata ba

Wadatacce

• Bita don

Wataƙila kun riga kun san cewa shan aspirin na iya zama taimako don hana bugun zuciya-shine tushen kamfen ɗin tallan samfurin Bayer Aspirin. Amma wataƙila ba ku san cewa sanannen sanannen binciken 1989 wanda ya tabbatar da tasirin miyagun ƙwayoyi a cikin waɗannan yanayin ya haɗa da maza sama da 20,000 da mata.

Me yasa wannan? Don yawancin tarihin likita, maza (da dabbobin maza) sun kasance "aladu na Guinea" don gwaji-sakamakon gwaji, allurai, da kuma sakamako masu illa da aka auna akan farko ko gaba ɗaya batutuwa na maza. A maganin zamani, maza sun kasance abin koyi; mata sukan zama abin birgewa.

Abin takaici, halin da ake ciki na yin watsi da tasirin magunguna a cikin mata yana ci gaba a yau. A cikin 2013, shekaru 20 bayan da magani ya fara samuwa, Hukumar Abinci da Magunguna (FDA) ta yanke shawarar shawarar Ambien ga mata a cikin rabin (daga 10 MG zuwa 5 MG don sigar sakin nan da nan). Ya juya cewa mata-kashi 5 cikin ɗari waɗanda ke ba da rahoton yin amfani da magungunan bacci da aka rubuta idan aka kwatanta da kawai kashi 3 cikin ɗari na mutanen da ke sarrafa maganin a hankali fiye da maza, ma'ana za su ji daɗin bacci yayin rana a mafi girman kashi. Wannan sakamako na gefe yana zuwa tare da mummunan tasiri, gami da haɗarin tuƙi.

Wasu bincike sun nuna cewa mata suna amsa magunguna iri -iri daban daban da maza. Alal misali, a cikin gwaji ɗaya, mahalarta maza masu shan statins sun sami raguwar ciwon zuciya da bugun jini, amma mata marasa lafiya ba su nuna irin wannan babban tasiri ba. Don haka yana iya, a zahiri, ya zama cutarwa don rubuta statins-wanda galibi yana zuwa tare da sanannen illa mara kyau-ga mata masu ko ba tare da haɗarin matsalolin zuciya ba.

A wasu lokuta, mata sun fi maza su yi amfani da magungunan SSRI, kuma wasu bincike sun nuna cewa maza suna da babban nasara tare da magungunan tricyclic. Har ila yau, matan da suka kamu da hodar iblis suna nuna bambance-bambance a cikin ayyukan kwakwalwa idan aka kwatanta da maza, suna ba da shawarar hanyar da mata za su iya dogara da miyagun ƙwayoyi da sauri. Sabili da haka, barin ƙirar mata daga nazarin jaraba, alal misali, mai yuwuwar yana da tasiri mai mahimmanci ga magunguna da ƙa'idodin kulawa waɗanda daga baya aka haɓaka don bautar masu shaye-shaye.

Mun kuma san cewa mata suna nuna alamomi daban -daban a wasu manyan cututtuka. Lokacin da mata suka sami bugun zuciya, alal misali, suna iya ko ba za su ji irin yanayin ciwon ƙirji ba. Maimakon haka, sun fi maza samun ƙarancin numfashi, sanyin gumi, da haske. Ko da yake jima'i ba abu ne mai mahimmanci ba a kowane bangare na kiwon lafiya, idan ya kasance, yana da tsanani.

Phyllis Greenberger, shugabar kuma Shugaba na Society for Women Health Bincike. Kwanan nan ta kasance wani ɓangare na taƙaitaccen taron majalisa don tattauna rawar da bambance-bambancen jinsi a cikin binciken likita, wanda ƙungiyarsa da The Endocrine Society suka haɗa kai.

Ƙungiyar Greenberger kuma tana da mahimmanci don taimakawa Dokar Farfaɗowar NIH ta 1993 ta wuce, wanda ke buƙatar duk Cibiyar Kiwon Lafiya ta Kasa (NIH) ta ba da kuɗin gwajin asibiti don haɗawa da mata da 'yan tsiraru. A halin yanzu, wannan rukunin yana ɗaya daga cikin mutane da yawa da ke aiki don samun la'akari iri ɗaya ga dabbobi da ƙwayoyin da aka yi amfani da su a cikin bincike na asali-ba kawai mutane ba.

Abin godiya, NIH tana matsawa don yin babban canji na dindindin a cikin bincike. Tun daga watan Satumba na bara, ya fara gabatar da jerin tsare-tsare, ƙa'idodi, da tallafi na ƙarfafawa don ƙarfafa (kuma a yawancin lokuta ya zama dole) masu bincike su gane jima'i na halitta a matsayin muhimmiyar mahimmanci a cikin aikin su. [Karanta cikakken labarin akan Refinery29!]

Bita don